Applications of MALDI-TOF mass spectrometry in clinical proteomics

ABSTRACT Introduction: The development of precision medicine requires advanced technologies to address the multifactorial disease stratification and to support personalized treatments. Among omics techniques, proteomics based on Mass Spectrometry (MS) is becoming increasingly relevant in clinical practice allowing a phenotypic characterization of the dynamic functional status of the organism. From this perspective, Matrix Assisted Laser Desorption Ionization Time of Flight (MALDI-TOF) MS is a suitable platform for providing a high-throughput support to clinics. Areas covered: This review aims to provide an updated overview of MALDI-TOF MS applications in clinical proteomics. The most relevant features of this analysis have been discussed, highlighting both pre-analytical and analytical factors that are crucial in proteomics studies. Particular emphasis is placed on biofluids proteomics for biomarkers discovery and on recent progresses in clinical microbiology, drug monitoring, and minimal residual disease (MRD). Expert commentary: Despite some analytical limitations, the latest technological advances together with the easiness of use, the low time and low cost consuming and the high throughput are making MALDI-TOF MS instruments very attractive for the clinical practice. These features offer a significant potential for the routine of the clinical laboratory and ultimately for personalized medicine.

[1]  Atta-ur-rahman,et al.  Comparison of plasma from healthy nonsmokers, smokers, and lung cancer patients: Pattern-based differentiation profiling of low molecular weight proteins and peptides by magnetic bead technology with MALDI-TOF MS , 2012, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[2]  Min-Seok Kwon,et al.  Overview and introduction to clinical proteomics. , 2008, Methods in molecular biology.

[3]  S. Winiarczyk,et al.  Applicability of 2D gel electrophoresis and liquid chromatography in proteomic analysis of urine using mass spectrometry MALDI-TOF. , 2013, Polish journal of veterinary sciences.

[4]  T. Veenstra,et al.  Analysis of biofluids for biomarker research , 2008, Proteomics. Clinical applications.

[5]  Y. Iwadate,et al.  Direct application of MALDI-TOF mass spectrometry to cerebrospinal fluid for rapid pathogen identification in a patient with bacterial meningitis. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[6]  Cheng-Huang Lin,et al.  Rapid drug-screening of clandestine tablets by MALDI-TOF mass spectrometry. , 2005, Talanta.

[7]  S. Rauser,et al.  Direct molecular tissue analysis by MALDI imaging mass spectrometry in the field of gastrointestinal disease. , 2012, Gastroenterology.

[8]  A. Vlahou,et al.  Biological sample collection for clinical proteomics: existing SOPs. , 2015, Methods in molecular biology.

[9]  José Luís Oliveira,et al.  From the salivary proteome to the OralOme: comprehensive molecular oral biology. , 2012, Archives of oral biology.

[10]  N. Voelcker,et al.  Surface-assisted laser desorption ionization mass spectrometry techniques for application in forensics. , 2015, Mass spectrometry reviews.

[11]  B. A. Mamyrin.  Laser assisted reflectron time-of-flight mass spectrometry , 1994 .

[12]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[13]  Kristina Schwamborn,et al.  MALDI imaging mass spectrometry - From bench to bedside. , 2017, Biochimica et biophysica acta. Proteins and proteomics.

[14]  Yu-Ying He,et al.  Serum proteomic profiling for autism using magnetic bead-assisted matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a pilot study , 2018, World Journal of Pediatrics.

[15]  N. T. ten Hacken,et al.  Assuring Consistent Performance of an Insulin-Like Growth Factor 1 MALDImmunoassay by Monitoring Measurement Quality Indicators , 2017, Analytical chemistry.

[16]  E. Petricoin,et al.  Use of proteomic patterns in serum to identify ovarian cancer , 2002, The Lancet.

[17]  Hui Zhang,et al.  Reproducibility in urine peptidome profiling using MALDI‐TOF , 2015, Proteomics.

[18]  N. Singhal,et al.  MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis , 2015, Front. Microbiol..

[19]  André M Deelder,et al.  De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry , 2015, The Journal of pathology.

[20]  Ying Ge,et al.  Top‐down proteomics in health and disease: Challenges and opportunities , 2014, Proteomics.

[21]  A. Messina,et al.  CSF N-glycoproteomics for early diagnosis in Alzheimer's disease. , 2016, Journal of proteomics.

[22]  J. Reilly,et al.  Optimization of guanidination procedures for MALDI mass mapping. , 2002, Analytical chemistry.

[23]  K. Rose,et al.  A Stable Isotope Dilution Assay for the In Vivo Determination of Insulin Levels in Humans by Mass Spectrometry , 1997, Diabetes.

[24]  M. Karas,et al.  Influence of the wavelength in high-irradiance ultraviolet laser desorption mass spectrometry of organic molecules , 1985 .

[25]  Rong Zhou,et al.  Plasmonic Thermal Decomposition/Digestion of Proteins: A Rapid On-Surface Protein Digestion Technique for Mass Spectrometry Imaging. , 2017, Analytical chemistry.

[26]  M. Lise,et al.  Protein profiles in sera of patients with malignant cutaneous melanoma. , 2000, Rapid communications in mass spectrometry : RCM.

[27]  C. Fanali,et al.  The human salivary proteome: a critical overview of the results obtained by different proteomic platforms , 2012, Expert review of proteomics.

[28]  R. Dziadziuszko,et al.  Serum mass profile signature as a biomarker of early lung cancer. , 2016, Lung cancer.

[29]  Jiaxiang Wang,et al.  Identification of Apolipoprotein C-I Peptides as a Potential Biomarker and its Biological Roles in Breast Cancer , 2016, Medical science monitor : international medical journal of experimental and clinical research.

[30]  N. Voelcker,et al.  Comparison of the performance of different silicon-based SALDI substrates for illicit drug detection. , 2015, Talanta.

[31]  R. Caprioli,et al.  Lung cancer diagnosis from proteomic analysis of preinvasive lesions. , 2011, Cancer research.

[32]  E. Ragazzi,et al.  Low molecular weight proteins in urines from healthy subjects as well as diabetic, nephropathic and diabetic-nephropathic patients: a MALDI study. , 2009, Journal of mass spectrometry : JMS.

[33]  H. Klocker,et al.  MALDI-MS tissue imaging identification of biliverdin reductase B overexpression in prostate cancer. , 2013, Journal of proteomics.

[34]  K. Thoren.  Mass spectrometry methods for detecting monoclonal immunoglobulins in multiple myeloma minimal residual disease. , 2018, Seminars in hematology.

[35]  B. Baune,et al.  The use of MALDI‐MSI in the investigation of psychiatric and neurodegenerative disorders: A review , 2016, Proteomics.

[36]  R. Caprioli,et al.  Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. , 1997, Analytical chemistry.

[37]  N. Verrills.  Clinical proteomics: present and future prospects. , 2006, The Clinical biochemist. Reviews.

[38]  T. Hankemeier,et al.  The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF). , 2009, Journal of proteome research.

[39]  Joanna Polanska,et al.  Molecular profiles of thyroid cancer subtypes: Classification based on features of tissue revealed by mass spectrometry imaging. , 2017, Biochimica et biophysica acta. Proteins and proteomics.

[40]  Wen-Jeng Wu,et al.  Using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to rapidly screen for albuminuria. , 2008, Rapid communications in mass spectrometry : RCM.

[41]  A. Ewing,et al.  Spatial neuroproteomics using imaging mass spectrometry. , 2015, Biochimica et biophysica acta.

[42]  G. Thorsen,et al.  Glycosylation patterns of selected proteins in individual serum and cerebrospinal fluid samples , 2017, Journal of pharmaceutical and biomedical analysis.

[43]  M. Scholle,et al.  High-Throughput Screening of Small Molecule Libraries using SAMDI Mass Spectrometry , 2011, ACS combinatorial science.

[44]  M. Plebani,et al.  A highly specific method for the characterization of glycation and glyco-oxidation products of globins. , 1997, Rapid communications in mass spectrometry : RCM.

[45]  Dante Mantini,et al.  Pre-analytical factors in clinical proteomics investigations: impact of ex vivo protein modifications for multiple sclerosis biomarker discovery. , 2010, Journal of proteomics.

[46]  D. Muddiman,et al.  Quantitative measurement of cyclosporin A in blood by time-of-flight mass spectrometry. , 1994, Analytical chemistry.

[47]  Pierre Thibault,et al.  Sample preparation and analytical strategies for large-scale phosphoproteomics experiments. , 2012, Seminars in cell & developmental biology.

[48]  K. Schey,et al.  Optimization of a MALDI TOF-TOF mass spectrometer for intact protein analysis , 2005, Journal of the American Society for Mass Spectrometry.

[49]  Wen-Jeng Wu,et al.  Diagnosis of albuminuria by tryptic digestion and matrix-assisted laser desorption ionization/time-of-flight mass spectrometry. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[50]  R. Savino,et al.  Influence of storage conditions on MALDI‐TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations , 2016, Proteomics.

[51]  Youxin Wang,et al.  Serum peptidome profiling for the diagnosis of colorectal cancer: discovery and validation in two independent cohorts , 2017, Oncotarget.

[52]  Giovanna E Carpagnano,et al.  Peptidome profiling of induced sputum by mesoporous silica beads and MALDI‐TOF MS for non‐invasive biomarker discovery of chronic inflammatory lung diseases , 2011, Proteomics.

[53]  T. Wakabayashi,et al.  Biomarker research for moyamoya disease in cerebrospinal fluid using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. , 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[54]  W. Vach,et al.  Serum protein profiling by solid phase extraction and mass spectrometry: A future diagnostics tool? , 2009, Proteomics.

[55]  Pierre Chaurand,et al.  Development of Laser Desorption Imaging Mass Spectrometry Methods to Investigate the Molecular Composition of Latent Fingermarks , 2015, Journal of The American Society for Mass Spectrometry.

[56]  Christoph H Borchers,et al.  Pre-analytical and analytical variability in absolute quantitative MRM-based plasma proteomic studies. , 2013, Bioanalysis.

[57]  Michel Salzet,et al.  Multivariate analyses for biomarkers hunting and validation through on-tissue bottom-up or in-source decay in MALDI-MSI: application to prostate cancer , 2011, Analytical and bioanalytical chemistry.

[58]  Silvia Angeletti,et al.  Matrix assisted laser desorption time of flight mass spectrometry (MALDI-TOF MS) in clinical microbiology. , 2017, Journal of microbiological methods.

[59]  Shou-rong Shen,et al.  Impact of experimental and demographic variables in serum peptide profiling based on magnetic bead and MALDI-TOF mass spectrometry. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[60]  K. Rose,et al.  Positive and Negative Labeling of Human Proinsulin, Insulin, and C-Peptide with Stable Isotopes , 2000 .

[61]  H. Cuckle,et al.  Direct and rapid mass spectral fingerprinting of maternal urine for the detection of Down syndrome pregnancy , 2015, Clinical Proteomics.

[62]  C. Stratton,et al.  Mass Spectrometry Biotyper System Identifies Enteric Bacterial Pathogens Directly from Colonies Grown on Selective Stool Culture Media , 2010, Journal of Clinical Microbiology.

[63]  J. Coorssen,et al.  2DE: the phoenix of proteomics. , 2014, Journal of proteomics.

[64]  Brian L Hood,et al.  Biomarkers: Mining the Biofluid Proteome* , 2005, Molecular & Cellular Proteomics.

[65]  C. Huck,et al.  Alternative profiling platform based on MELDI and its applicability in clinical proteomics , 2007, Expert review of proteomics.

[66]  D. Centonze,et al.  Oxidative modifications of cerebral transthyretin are associated with multiple sclerosis , 2013, Proteomics.

[67]  A. Urbani,et al.  A quantitative method for the analysis of glycated and glutathionylated hemoglobin by matrix-assisted laser desorption ionization-time of flight mass spectrometry. , 2005, Analytical biochemistry.

[68]  Direct identification of forensic body fluids using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry , 2016 .

[69]  Weimin Zhu,et al.  Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. , 2003, Journal of proteome research.

[70]  Stefani N. Thomas,et al.  Advances in mass spectrometry-based clinical biomarker discovery , 2016, Clinical Proteomics.

[71]  J. Albrethsen.  Reproducibility in protein profiling by MALDI-TOF mass spectrometry. , 2007, Clinical chemistry.

[72]  M. Agostini,et al.  Cross-validation of a mass spectrometric-based method for the therapeutic drug monitoring of irinotecan: implementation of matrix-assisted laser desorption/ionization mass spectrometry in pharmacokinetic measurements , 2016, Analytical and Bioanalytical Chemistry.

[73]  D. Newton,et al.  Cost Analysis of Implementing Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry Plus Real-Time Antimicrobial Stewardship Intervention for Bloodstream Infections , 2016, Journal of Clinical Microbiology.

[74]  V. Paradis,et al.  In situ proteomic analysis by MALDI imaging identifies ubiquitin and thymosin-β4 as markers of malignant intraductal pancreatic mucinous neoplasms. , 2014, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[75]  S. Fisher,et al.  Evaluating the effects of preanalytical variables on the stability of the human plasma proteome. , 2015, Analytical biochemistry.

[76]  M. Hou,et al.  Biomarker Characterization by MALDI-TOF/MS. , 2015, Advances in clinical chemistry.

[77]  Frank Vitzthum,et al.  Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics , 2006, Expert review of proteomics.

[78]  C. Deng,et al.  Facile synthesis of thiol-polyethylene glycol functionalized magnetic titania nanomaterials for highly efficient enrichment of N-linked glycopeptides. , 2017, Journal of chromatography. A.

[79]  Randall W. Nelson,et al.  Parallel Workflow for High-Throughput (>1,000 Samples/Day) Quantitative Analysis of Human Insulin-Like Growth Factor 1 Using Mass Spectrometric Immunoassay , 2014, PloS one.

[80]  M. Glocker,et al.  Proteoform profiling of peripheral blood serum proteins from pregnant women provides a molecular IUGR signature. , 2016, Journal of proteomics.

[81]  Chuan-Fa Chang,et al.  Serum N-glycome characterization and anti-carbohydrate antibody profiling in oral squamous cell carcinoma patients , 2017, PloS one.

[82]  E. Ragazzi,et al.  A further investigation on a MALDI-based method for evaluation of markers of renal damage. , 2009, Journal of mass spectrometry : JMS.

[83]  L. Milroy,et al.  A sample preparation method for recovering suppressed analyte ions in MALDI TOF MS. , 2015, Journal of mass spectrometry : JMS.

[84]  W. Dyszkiewicz,et al.  Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer , 2016, International journal of molecular sciences.

[85]  Adel Hafiane,et al.  Application of chemometric algorithms to MALDI mass spectrometry imaging of pharmaceutical tablets. , 2015, Journal of pharmaceutical and biomedical analysis.

[86]  N. Voelcker,et al.  Rapid detection of illicit drugs in neat saliva using desorption/ionization on porous silicon. , 2012, Talanta.

[87]  Leif E. Peterson,et al.  Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. , 2013, Archives of pathology & laboratory medicine.

[88]  B. Döme,et al.  Drug localization in different lung cancer phenotypes by MALDI mass spectrometry imaging. , 2011, Journal of proteomics.

[89]  Malte Buchholz,et al.  MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large‐scale tissue microarrays , 2013, International journal of cancer.

[90]  J. Sung,et al.  Technical evaluation of MALDI-TOF mass spectrometry for quantitative proteomic profiling matrix formulation and application , 2004, Clinical Proteomics.

[91]  Christoph H Borchers,et al.  Recent advancements in matrix-assisted laser desorption/ionization mass spectrometry imaging. , 2017, Current opinion in biotechnology.

[92]  U. Markert,et al.  Serum Protein Profile in Women With Pregnancy Morbidity Associated With Antiphospholipid Syndrome , 2017, Journal of human reproductive sciences.

[93]  J. Larkin,et al.  Recent advances in SALDI-MS techniques and their chemical and bioanalytical applications , 2011, Analytical and bioanalytical chemistry.

[94]  T. Mizukoshi,et al.  The effects of pre-analysis sample handling on human plasma amino acid concentrations. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[95]  K. Syrigos,et al.  Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study. , 2017, Lung cancer.

[96]  T. Veenstra,et al.  Analytical and preanalytical biases in serum proteomic pattern analysis for breast cancer diagnosis. , 2005, Clinical chemistry.

[97]  E. Smit,et al.  Response and toxicity prediction by MALDI‐TOF‐MS serum peptide profiling in patients with non‐small cell lung cancer , 2016, Proteomics. Clinical applications.

[98]  K. Gilany,et al.  Exploring the Human Seminal Plasma Proteome: An Unexplored Gold Mine of Biomarker for Male Infertility and Male Reproduction Disorder , 2015, Journal of reproduction & infertility.

[99]  E. Nordhoff,et al.  High-throughput proteomics using matrix-assisted laser desorption/ ionization mass spectrometry , 2005, Expert review of proteomics.

[100]  M. Scholle,et al.  Identification of Small-Molecule Noncovalent Binders Utilizing SAMDI Technology , 2017, SLAS discovery : advancing life sciences R & D.

[101]  W. Alley,et al.  Complementary Glycomic Analyses of Sera Derived from Colorectal Cancer Patients by MALDI-TOF-MS and Microchip Electrophoresis. , 2016, Analytical chemistry.

[102]  Koichi Tanaka,et al.  Protein and polymer analyses up to m/z 100 000 by laser ionization time-of-flight mass spectrometry , 1988 .

[103]  Ákos Végvári,et al.  Novel insights in drug metabolism by MS imaging. , 2016, Bioanalysis.

[104]  Laura M Cole,et al.  Mass spectrometry imaging tools in oncology. , 2015, Biomarkers in medicine.

[105]  S. Hattan,et al.  Applications of MALDI Mass Spectrometry in Clinical Chemistry. , 2016, Clinical chemistry.

[106]  K. Wolff,et al.  Rapid detection of cocaine, benzoylecgonine and methylecgonine in fingerprints using surface mass spectrometry. , 2015, The Analyst.

[107]  W. Crielaard,et al.  A Study of the Variation in the Salivary Peptide Profiles of Young Healthy Adults Acquired Using MALDI-TOF MS , 2016, PloS one.

[108]  M. B. Tracy,et al.  Enhancement in MALDI-TOF MS analysis of the low molecular weight human serum proteome. , 2011, Journal of mass spectrometry : JMS.

[109]  H. Vrenken,et al.  Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry , 2011, Multiple sclerosis.

[110]  A. Guttman,et al.  Material-enhanced laser desorption/ionization (MELDI)—A new protein profiling tool utilizing specific carrier materials for time of flight mass spectrometric analysis , 2006, Journal of the American Society for Mass Spectrometry.

[111]  Juri Rappsilber,et al.  Experiences and perspectives of MALDI MS and MS/MS in proteomic research , 2003 .

[112]  Cristian Piras,et al.  Direct Assessment of Plasma/Serum Sample Quality for Proteomics Biomarker Investigation. , 2017, Methods in molecular biology.

[113]  A. Vlahou,et al.  Clinical Proteomics for Precision Medicine: The Bladder Cancer Case , 2018, Proteomics. Clinical applications.

[114]  M. Roberts,et al.  Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in clinical chemistry. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[115]  Shen Hu,et al.  Human saliva proteome analysis and disease biomarker discovery , 2007, Expert review of proteomics.

[116]  C. Liang,et al.  Magnetic Bead-based Salivary Peptidome Profiling for Accelerated Osteogenic Orthodontic Treatments. , 2018, The Chinese journal of dental research : the official journal of the Scientific Section of the Chinese Stomatological Association.

[117]  F. Chen,et al.  Screening for potential serum‐based proteomic biomarkers for human type 2 diabetes mellitus using MALDI‐TOF MS , 2017, Proteomics. Clinical applications.

[118]  Mark W. Duncan,et al.  Practical quantitative biomedical applications of MALDI-TOF mass spectrometry , 2002, Journal of the American Society for Mass Spectrometry.

[119]  P. Traldi,et al.  Mass Spectrometry for Diabetic Nephropathy Monitoring: New Effective Tools for Physicians , 2012, ISRN endocrinology.

[120]  M. Malaise,et al.  Biomarkers of inflammation and innate immunity in atrophic nonunion fracture , 2016, Journal of Translational Medicine.

[121]  C. Deng,et al.  Rapid synthesis of titanium(IV)‐immobilized magnetic mesoporous silica nanoparticles for endogenous phosphopeptides enrichment , 2017, Proteomics.

[122]  Ji-fan Hu,et al.  Serum peptidomic profiling identifies a minimal residual disease detection and prognostic biomarker for patients with acute leukemia , 2013, Oncology letters.

[123]  V. Adam,et al.  MALDI-TOF MS as evolving cancer diagnostic tool: a review. , 2014, Journal of pharmaceutical and biomedical analysis.

[124]  Z. Kokot,et al.  MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancer , 2017, BMC Cancer.

[125]  Michelle L. Reyzer,et al.  Gastric cancer-specific protein profile identified using endoscopic biopsy samples via MALDI mass spectrometry. , 2010, Journal of proteome research.

[126]  Torben A. Kruse,et al.  Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry. , 2008, Rapid communications in mass spectrometry : RCM.

[127]  J. Montaner,et al.  Profiling and identification of new proteins involved in brain ischemia using MALDI-imaging-mass-spectrometry. , 2017, Journal of proteomics.

[128]  M. Zeegers,et al.  Assessment of high‐throughput high‐resolution MALDI‐TOF‐MS of urinary peptides for the detection of muscle‐invasive bladder cancer , 2011, Proteomics. Clinical applications.

[129]  Shanshan Wang,et al.  Identification of urine biomarkers associated with lung adenocarcinoma , 2017, Oncotarget.

[130]  S. Bencharit,et al.  Defining salivary biomarkers using mass spectrometry-based proteomics: a systematic review. , 2011, Omics : a journal of integrative biology.

[131]  Z. Kokot,et al.  Challenges in biomarker discovery with MALDI-TOF MS. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[132]  Brian T Chait,et al.  On the mature of the chemical noise in MALDI mass spectra , 2002, Journal of the American Society for Mass Spectrometry.

[133]  E. Diamandis,et al.  Application of proteomics to prenatal screening and diagnosis for aneuploidies , 2011, Clinical chemistry and laboratory medicine.

[134]  Ignazio Garaguso,et al.  Matrix layer sample preparation: An improved MALDI‐MS peptide analysis method for proteomic studies , 2008, Proteomics.

[135]  Z. Shahrokh,et al.  Mass Spectrometry Innovations in Drug Discovery and Development , 2001, Pharmaceutical Research.

[136]  M. Trojano,et al.  Proteomic Profiling in Multiple Sclerosis Clinical Courses Reveals Potential Biomarkers of Neurodegeneration , 2014, PloS one.

[137]  R. Aebersold,et al.  Direct analytical sample quality assessment for biomarker investigation: Qualifying cerebrospinal fluid samples , 2014, Proteomics.

[138]  T. Luider,et al.  Biomedical application of MALDI mass spectrometry for small-molecule analysis. , 2011, Mass spectrometry reviews.

[139]  T. Poon,et al.  Advances in MALDI Mass Spectrometry in Clinical Diagnostic Applications , 2013, Topics in current chemistry.

[140]  R. Dougherty.  Mass spectrometry principles and applications , 1997 .

[141]  M. I. Mora,et al.  Multicentric study of the effect of pre-analytical variables in the quality of plasma samples stored in biobanks using different complementary proteomic methods. , 2017, Journal of proteomics.

[142]  Eilidh Martin,et al.  Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine , 2016, EPMA Journal.

[143]  Juan Yang,et al.  Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling , 2013, Proteome Science.

[144]  Shuguo Zheng,et al.  Longitudinal investigation of salivary proteomic profiles in the development of early childhood caries. , 2017, Journal of dentistry.

[145]  E. Van Obberghen,et al.  Fast urinary screening of oligosaccharidoses by MALDI-TOF/TOF mass spectrometry , 2014, Orphanet Journal of Rare Diseases.

[146]  G. Colella,et al.  Expression of salivary biomarkers in patients with oral mucositis: evaluation by SELDI-TOF/MS. , 2016, Oral diseases.

[147]  S. Hunsucker,et al.  Quantitative matrix-assisted laser desorption/ionization mass spectrometry. , 2008, Briefings in functional genomics & proteomics.

[148]  A. Messina,et al.  CSF N-Glycomics Using MALDI MS Techniques in Alzheimer's Disease. , 2018, Methods in molecular biology.